Log In
BCIQ
Print this Print this
 

Human serum albumin/interferon alpha2a fusion protein

  Manage Alerts
Collapse Summary General Information
Company FortuneRock Co. Ltd.
DescriptionRecombinant human serum albumin/interferon alpha2a fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic hepatitis B virus (HBV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today